Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

被引:53
|
作者
Beaton, Melanie D. [1 ]
机构
[1] Univ Western Ontario, Dept Med, Div Gastroenterol, London, ON, Canada
关键词
Fibrosis; Hepatic steatosis; Metabolic syndrome; Treatment; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR RISK-FACTORS; PLACEBO-CONTROLLED TRIAL; VITAMIN-E; URSODEOXYCHOLIC ACID; HEPATIC STEATOSIS; INSULIN-RESISTANCE; BARIATRIC SURGERY; IRON DEPLETION; METFORMIN;
D O I
10.1155/2012/725468
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
MD Beaton. current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. can J gastroenterol 2012;26(6):353-358. Nonalcoholic fatty liver disease is the leading cause of liver disease in western society. It is a cause of end-stage liver disease, with increased mortality secondary to cirrhosis and its complications. It is also recognized that cardiovascular disease is a significant cause of death in these patients. Significant work evaluating various treatments has been performed in recent years; however, to date, no ideal therapy exists. Lifestyle modification remains the cornerstone of management. The present article reviews the current status of various treatment modalities evaluated in nonalcoholic fatty liver disease.
引用
收藏
页码:353 / 357
页数:5
相关论文
共 50 条
  • [21] Nonalcoholic fatty liver disease
    Lemoine, Maud
    Serfaty, Lawrence
    PRESSE MEDICALE, 2012, 41 (02): : 169 - 189
  • [22] CURRENT THERAPIES FOR NONALCOHOLIC FATTY LIVER DISEASE
    Gossard, A. A.
    Lindor, K. D.
    DRUGS OF TODAY, 2011, 47 (12) : 915 - 922
  • [23] Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
    Kim, Kyung-Soo
    Lee, Byung-Wan
    Kim, Yong Jin
    Lee, Dae Ho
    Cha, Bong-Soo
    Park, Cheol-Young
    DIABETES & METABOLISM JOURNAL, 2019, 43 (02) : 127 - 143
  • [24] Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Takahashi, Yoshihisa
    Fukusato, Toshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15539 - 15548
  • [25] Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
    Okanoue, Takeshi
    Umemura, Atsushi
    Yasui, Kohichiroh
    Itoh, Yoshito
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 153 - 162
  • [26] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation
    Carter, Danielle
    Dieterich, Douglas T.
    Chang, Charissa
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 213 - +
  • [27] Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic steatohepatitis
    Manne, Vignan
    Handa, Priya
    Kowdley, Kris V.
    CLINICS IN LIVER DISEASE, 2018, 22 (01) : 23 - +
  • [28] Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease
    Torres, Dawn M.
    Williams, Christopher D.
    HarrisonO, Stephen A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (08) : 837 - 858
  • [29] Pharmacological management of nonalcoholic fatty liver disease
    Barb, Diana
    Portillo-Sanchez, Paola
    Cusi, Kenneth
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1183 - 1195
  • [30] Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Yoshihisa Takahashi
    Keiichiro Sugimoto
    Hiroshi Inui
    Toshio Fukusato
    World Journal of Gastroenterology, 2015, 21 (13) : 3777 - 3785